Toll Free: 1-888-928-9744

Epistem Holdings Plc - Product Pipeline Review - 2014

Published: Jan, 2014 | Pages: 20 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Epistem Holdings Plc - Product Pipeline Review - 2014

Summary

Global Market Direct's pharmaceuticals report, "Epistem Holdings Plc - Product Pipeline Review - 2014" provides data on the Epistem Holdings Plc's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. 

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Epistem Holdings Plc's corporate website, SEC filings, investor presentations and featured press releases, both from Epistem Holdings Plc and industry-specific third party sources, put together by Global Markets Direct's team. 

Scope

- Epistem Holdings Plc - Brief Epistem Holdings Plc overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Epistem Holdings Plc human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Epistem Holdings Plc with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones. 
- Recent updates of the Epistem Holdings Plc's pipeline in the last quarter. 
- Key discontinued and dormant projects. 
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Epistem Holdings Plc's strategic position with total access to detailed information on its product pipeline. 
- Assess the growth potential of Epistem Holdings Plc in its therapy areas of focus. 
- Identify new drug targets and therapeutic classes in the Epistem Holdings Plc's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. 
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. 
- Exploit collaboration and partnership opportunities with Epistem Holdings Plc. 
- Avoid Intellectual Property Rights related issues. 
- Explore the dormant and discontinued projects of Epistem Holdings Plc and identify potential opportunities in those areas.
 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Epistem Holdings Plc Snapshot 4
Epistem Holdings Plc Overview 4
Key Information 4
Key Facts 4
Epistem Holdings Plc - Research and Development Overview 5
Key Therapeutic Areas 5
Epistem Holdings Plc - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Epistem Holdings Plc - Pipeline Products Glance 9
Epistem Holdings Plc - Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
Epistem Holdings Plc - Drug Profiles 10
Epi-2221 10
Product Description 10
Mechanism of Action 10
R&D Progress 10
Epi-288 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
Epi-3905 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Epi-6 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Epistem Holdings Plc - Pipeline Analysis 14
Epistem Holdings Plc - Pipeline Products by Therapeutic Class 14
Epistem Holdings Plc - Pipeline Products by Molecule Type 15
Epistem Holdings Plc - Company Statement 16
Epistem Holdings Plc - Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
Coverage 19
Secondary Research 19
Primary Research 19
Expert Panel Validation 19
Contact Us 20
Disclaimer 20
List of Tables
Epistem Holdings Plc, Key Information 4
Epistem Holdings Plc, Key Facts 4
Epistem Holdings Plc - Pipeline by Indication, 2014 6
Epistem Holdings Plc - Pipeline by Stage of Development, 2014 7
Epistem Holdings Plc - Monotherapy Products in Pipeline, 2014 8
Epistem Holdings Plc - Preclinical, 2014 9
Epistem Holdings Plc - Pipeline by Therapeutic Class, 2014 14
Epistem Holdings Plc - Pipeline by Molecule Type, 2014 15
Epistem Holdings Plc, Subsidiaries 18 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify